Calliditas Therapeutics AB (publ) (CALT)
USD 40.0
(-0.1%)
USD 40.0
(-0.1%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 939.5 Million SEK | 28.91% |
| 2022 | 728.82 Million SEK | 241.82% |
| 2021 | 213.21 Million SEK | 24184.28% |
| 2020 | 878 Thousand SEK | -75.5% |
| 2019 | 3.58 Million SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.01 Billion SEK | 4.99% |
| 2024 Q2 | 982.48 Million SEK | -0.4% |
| 2023 Q2 | 779.56 Million SEK | 7.68% |
| 2023 FY | 939.5 Million SEK | 28.91% |
| 2023 Q4 | 939.5 Million SEK | 21.99% |
| 2023 Q3 | 770.16 Million SEK | -1.21% |
| 2023 Q1 | 723.99 Million SEK | -0.66% |
| 2022 Q4 | 728.82 Million SEK | 55.96% |
| 2022 Q3 | 467.31 Million SEK | 2.03% |
| 2022 Q2 | 458.02 Million SEK | 113.54% |
| 2022 Q1 | 214.49 Million SEK | 0.6% |
| 2022 FY | 728.82 Million SEK | 241.82% |
| 2021 Q3 | 187.42 Million SEK | 5288.93% |
| 2021 Q4 | 213.21 Million SEK | 13.76% |
| 2021 FY | 213.21 Million SEK | 24184.28% |
| 2021 Q2 | 3.47 Million SEK | 163.68% |
| 2021 Q1 | 1.31 Million SEK | 50.23% |
| 2020 Q1 | 2.33 Million SEK | -34.77% |
| 2020 Q4 | 878 Thousand SEK | -15.09% |
| 2020 Q3 | 1.03 Million SEK | -38.12% |
| 2020 Q2 | 1.67 Million SEK | -28.53% |
| 2020 FY | 878 Thousand SEK | -75.5% |
| 2019 Q2 | 4.86 Million SEK | 0.0% |
| 2019 Q3 | 4.21 Million SEK | -13.46% |
| 2019 Q4 | 3.58 Million SEK | -14.87% |
| 2019 FY | 3.58 Million SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Absci Corporation | 4.66 Million USD | -20061.116% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -619.048% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 59.902% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -351775.655% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -4712520.385% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -2244.082% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -8295.21% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -833.923% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -4872.257% |
| Chimerix, Inc. | 125 Thousand USD | -751506.4% |
| CRISPR Therapeutics AG | 223 Million USD | -321.291% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -387.752% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -19050.183% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1443.821% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1443.821% |
| Gritstone bio, Inc. | 40.14 Million USD | -2240.345% |
| Allakos Inc. | 38.21 Million USD | -2358.48% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -279.42% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -2433.801% |
| Cytokinetics, Incorporated | 607.37 Million USD | -54.684% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -10094.314% |
| Innoviva, Inc. | 446.23 Million USD | -110.542% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -3568645.727% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -20974.652% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -7157.69% |
| ImmuCell Corporation | 10.54 Million USD | -8813.319% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -83411.822% |
| Incyte Corporation | 29.16 Million USD | -3121.686% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -8416.156% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -689837.065% |
| Mustang Bio, Inc. | 1.97 Million USD | -47397.877% |
| MiMedx Group, Inc. | 48.09 Million USD | -1853.28% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 30.19 Million USD | -3011.366% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 5.3 Million USD | -17626.566% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -886.992% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -81.125% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1045.506% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -690714.706% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -1286897.26% |
| NextCure, Inc. | 5.94 Million USD | -15692.705% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -90411.368% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 118.85 Thousand USD | -790352.392% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -647836.552% |
| Opthea Limited | 200.53 Million USD | -368.499% |
| Ovid Therapeutics Inc. | 30 Million USD | -3031.693% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| PDS Biotechnology Corporation | 19.5 Million USD | -4716.463% |
| Precigen, Inc. | 5.89 Million USD | -15837.371% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -21463.186% |
| PureTech Health plc | 18.25 Million USD | -5047.989% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -4108.134% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 65.241% |
| Replimune Group, Inc. | 71.99 Million USD | -1205.053% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -1684.17% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -2453500.063% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -1066.004% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -2703.246% |
| Solid Biosciences Inc. | 23.94 Million USD | -3824.264% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -159680.272% |
| SciSparc Ltd. | 24 Thousand USD | -3914516.667% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -530.06% |
| TG Therapeutics, Inc. | 100.11 Million USD | -838.401% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -14219.585% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -149.033% |
| UroGen Pharma Ltd. | 98.55 Million USD | -853.322% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -2091.323% |
| XOMA Corporation | 118.51 Million USD | -692.713% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -2077.307% |
| AbCellera Biologics Inc. | 71.22 Million USD | -1219.126% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -28909.418% |
| Precision BioSciences, Inc. | 7.72 Million USD | -12065.065% |
| Dyadic International, Inc. | 88.87 Thousand USD | -1057071.149% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -680702.899% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -4270390.909% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -948897.98% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -11491.709% |
| IGM Biosciences, Inc. | 34.67 Million USD | -2609.702% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -1621.657% |
| Acelyrin, Inc. | 1.19 Million USD | -78585.762% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -21242.753% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -16225.074% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -1042361.497% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -3526.464% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -2618.798% |
| Senti Biosciences, Inc. | 33.53 Million USD | -2701.324% |
| Mesoblast Limited | 100.48 Million USD | -834.992% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -1099.438% |
| ChromaDex Corporation | 2.57 Million USD | -36385.748% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -1219.608% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -3518.503% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -392.064% |
| Novavax, Inc. | 168.01 Million USD | -459.178% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -864.984% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -1551.331% |
| Celcuity Inc. | 37.03 Million USD | -2436.783% |
| ContextLogic Inc. | 6 Million USD | -15558.467% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -579.306% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -24617.39% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 81.607% |
| Amarin Corporation plc | 8.73 Million USD | -10653.21% |
| AnaptysBio, Inc. | 16.03 Million USD | -5758.378% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -17307.967% |
| Aptorum Group Limited | 3.05 Million USD | -30617.934% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -10589.589% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -798.123% |
| Ardelyx, Inc. | 51.54 Million USD | -1722.624% |
| Celularity Inc. | 26.17 Million USD | -3489.059% |
| Omeros Corporation | 329.7 Million USD | -184.954% |
| Humacyte, Inc. | 38.6 Million USD | -2333.959% |
| Immunocore Holdings plc | 82.64 Million USD | -1036.813% |
| IO Biotech, Inc. | 1.83 Million USD | -50987.983% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -64338.134% |
| Summit Therapeutics Inc. | 103.29 Million USD | -809.583% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 8.32 Million USD | -11182.671% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -871.098% |
| Evogene Ltd. | 10.65 Million USD | -8719.187% |
| CorMedix Inc. | 517.01 Thousand USD | -181618.448% |
| BioLineRx Ltd. | 6.62 Million USD | -14074.834% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -59741.274% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -230.565% |
| scPharmaceuticals Inc. | 38.81 Million USD | -2320.726% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -10787.797% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -3663.451% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -6263286.667% |
| Lisata Therapeutics, Inc. | 137.00 USD | -685772162.774% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -19583.805% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -146240.81% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -23905.768% |
| bluebird bio, Inc. | 224.41 Million USD | -318.64% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -58.408% |
| DBV Technologies S.A. | 4.52 Million USD | -20658.02% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -15021.648% |
| Galecto, Inc. | 66 Thousand USD | -1423396.97% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -24827.249% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -54617.997% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -353.939% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -1405423.308% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -365.566% |
| ADMA Biologics, Inc. | 130.59 Million USD | -619.411% |
| Clene Inc. | 7.15 Million USD | -13036.298% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -85232.243% |
| Aptose Biosciences Inc. | 621 Thousand USD | -151189.533% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -92834.653% |
| Century Therapeutics, Inc. | 46.65 Million USD | -1913.605% |
| Kura Oncology, Inc. | 9.33 Million USD | -9967.595% |
| Surrozen, Inc. | 882 Thousand USD | -106420.181% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -3418.757% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -9910.741% |
| Autolus Therapeutics plc | 47.91 Million USD | -1860.821% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -13771.372% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -3526.324% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -3980.382% |
| INmune Bio, Inc. | 397 Thousand USD | -236551.889% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -440.715% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -23073.353% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -2931.355% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -639242.901% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -1787.624% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -2137.563% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -1956.131% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -98.473% |
| Verastem, Inc. | 40.08 Million USD | -2243.731% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -9244.619% |
| Histogen Inc. | 4.38 Million USD | -21330.383% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -1865.498% |
| Surrozen, Inc. | 882 Thousand USD | -106420.181% |
| Organovo Holdings, Inc. | 888 Thousand USD | -105700.45% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -1141.094% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -1008995.205% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -3601.911% |
| Turnstone Biologics Corp. | 1.18 Million USD | -78916.653% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -861833.945% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -1457.514% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -1045.616% |
| Exelixis, Inc. | 189.94 Million USD | -394.624% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -3962.737% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -909.865% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -51692.062% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -511.687% |
| Insmed Incorporated | 1.19 Billion USD | 21.272% |
| MediWound Ltd. | 6.35 Million USD | -14695.402% |
| OmniAb, Inc. | 22.07 Million USD | -4155.982% |
| Alector, Inc. | 30.45 Million USD | -2984.804% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -825.223% |
| Zai Lab Limited | 8.04 Million USD | -11575.258% |
| AlloVir, Inc. | 16.64 Million USD | -5543.369% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -120.234% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -12592153.049% |
| Aura Biosciences, Inc. | 16.87 Million USD | -5469.105% |
| Immunic, Inc. | 639 Thousand USD | -146927.856% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -3050.703% |
| Veracyte, Inc. | 7.52 Million USD | -12385.156% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -45.691% |
| FibroGen, Inc. | 89.69 Million USD | -947.424% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -21562.624% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -29370.138% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -717832.494% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -2539110.811% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -47349.899% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 42.446% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -15519.418% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -51692.062% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -6890.907% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -204140.87% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -4280.603% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -2470.122% |
| Agenus Inc. | 137.32 Million USD | -584.154% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -181623.017% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1976.903% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -2972.899% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -1997.022% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -15.808% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -209119.847% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -1328.757% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -297212.658% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -1527654.651% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 5.92 Million USD | -15765.897% |
| Pluri Inc. | 29.05 Million USD | -3133.773% |
| Prothena Corporation plc | 10.72 Million USD | -8663.25% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -4632.799% |
| Rallybio Corporation | 173 Thousand USD | -542968.208% |
| Kodiak Sciences Inc. | 100 Million USD | -839.508% |
| Cue Biopharma, Inc. | 4.2 Million USD | -22258.591% |
| MeiraGTx Holdings plc | 72.11 Million USD | -1202.719% |
| Annexon, Inc. | 29.19 Million USD | -3118.595% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -83635.116% |
| Moderna, Inc. | - USD | -Infinity% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -58146.001% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -26165.25% |
| Blueprint Medicines Corporation | 610.96 Million USD | -53.775% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -2091.17% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -1829.809% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -3598.268% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -933.551% |
| Elicio Therapeutics, Inc. | 6 Million USD | -15540.22% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -200221.535% |
| Nutriband Inc. | 79.82 Thousand USD | -1176844.855% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -20852.453% |
| Vor Biopharma Inc. | 31.83 Million USD | -2851.643% |
| Roivant Sciences Ltd. | 477.85 Million USD | -96.609% |
| Alkermes plc | 287.73 Million USD | -226.524% |
| ProKidney Corp. | 3.61 Million USD | -25925.152% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -123682.345% |
| Arcellx, Inc. | 50.84 Million USD | -1747.934% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 45.872% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -2450.377% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -1209.583% |
| Atai Life Sciences N.V. | 15.21 Million USD | -6076.504% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -111428.997% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -368334.51% |
| MediciNova, Inc. | 410.66 Thousand USD | -228680.013% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -68527.319% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -141584.424% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -427.606% |
| Biomea Fusion, Inc. | 7.83 Million USD | -11898.825% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -43598.047% |
| Geron Corporation | 35.05 Million USD | -2580.403% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -8054.036% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -4039.714% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -9290.385% |
| Royalty Pharma plc | 6.13 Billion USD | 84.687% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -8066.084% |
| Imunon, Inc. | 1.13 Million USD | -82364.125% |
| BioAtla, Inc. | 836 Thousand USD | -112281.34% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -963.441% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -19851.327% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -3958.701% |
| Structure Therapeutics Inc. | 4.01 Million USD | -23311.612% |
| 89bio, Inc. | 24.79 Million USD | -3689.103% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -9230.698% |
| aTyr Pharma, Inc. | 13.76 Million USD | -6724.348% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -11794.012% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -4549.879% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -337621.701% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -6399.6% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 37.335% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -844.153% |
| Liquidia Corporation | 2.36 Million USD | -39642.301% |
| Entera Bio Ltd. | 256 Thousand USD | -366895.313% |
| GH Research PLC | 631 Thousand USD | -148791.918% |
| Vericel Corporation | 81.85 Million USD | -1047.757% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -13412.268% |
| Xencor, Inc. | 14.64 Million USD | -6316.528% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -625192.344% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -626238.667% |
| Vaxcyte, Inc. | 22.11 Million USD | -4149.053% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -9682.466% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -13310.049% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -689837.065% |
| Portage Biotech Inc. | 7000.00 USD | -13421442.857% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -141584.424% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -65645.836% |
| OncoCyte Corporation | 2.2 Million USD | -42527.405% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -1404141.835% |
| Purple Biotech Ltd. | 163 Thousand USD | -576285.276% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -14898.531% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -77802.819% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -191636.327% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -36961.46% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -198108.439% |
| United Therapeutics Corporation | 300 Million USD | -213.169% |
| HilleVax, Inc. | 25.24 Million USD | -3621.708% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -465.611% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -100597.535% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -50601.997% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -4574.402% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -3465.766% |
| Windtree Therapeutics, Inc. | 15 Million USD | -6163.387% |
| Curis, Inc. | 1.48 Million USD | -62996.575% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -134554.981% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -15658366.667% |
| BeiGene, Ltd. | 197.61 Million USD | -375.416% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -1710.611% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -70012.537% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -24840.483% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -101140.086% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -5278.76% |
| Adicet Bio, Inc. | 17.7 Million USD | -5207.055% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -142.23% |
| Aditxt, Inc. | 1.04 Million USD | -90086.073% |
| Adagene Inc. | 13.54 Million USD | -6838.742% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -6739.252% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -5396.449% |
| Compugen Ltd. | 719 Thousand USD | -130568.707% |
| Generation Bio Co. | 89.77 Million USD | -946.526% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -4134.879% |
| Invivyd, Inc. | 722 Thousand USD | -130025.762% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -1837.05% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -32133783.772% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -24462.301% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -4084717.391% |
| 2seventy bio, Inc. | 244.01 Million USD | -285.024% |
| Instil Bio, Inc. | 81.42 Million USD | -1053.804% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -27726.894% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -1434504.285% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -357310.838% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -9646.945% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -741.303% |
| Evaxion Biotech A/S | 8.48 Million USD | -10967.685% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -1153.931% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -1351.762% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -15014.35% |
| Cingulate Inc. | 135.09 Thousand USD | -695321.876% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -3891.283% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -521848.889% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -5288.014% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -100274.786% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -713.568% |
| ImmunityBio, Inc. | 836.95 Million USD | -12.254% |
| Korro Bio, Inc. | 31.21 Million USD | -2909.7% |
| Kineta, Inc. | 150 Thousand USD | -626238.667% |
| BioVie Inc. | 349.89 Thousand USD | -268412.178% |
| Codexis, Inc. | 12.24 Million USD | -7573.838% |
| Celularity Inc. | 26.17 Million USD | -3489.059% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -927.796% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -1875.624% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -532667.019% |
| Cibus, Inc. | 17.67 Million USD | -5215.763% |
| IN8bio, Inc. | 3.37 Million USD | -27704.321% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -1353.739% |
| Avalo Therapeutics, Inc. | 2 Million USD | -46875.4% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 32.91% |
| Eyenovia, Inc. | 8.95 Million USD | -10388.822% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -1330.89% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -3017.457% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -11439.032% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -64338.134% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -4323.712% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -88952.891% |
| Moolec Science SA | 99.04 Thousand USD | -948457.236% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -3301.426% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -158869.205% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -57117.296% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -175181.343% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -2959726.098% |
| Humacyte, Inc. | 38.6 Million USD | -2333.959% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -7455.959% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -50248.767% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -90937.597% |
| Notable Labs, Ltd. | 1.52 Million USD | -61466.71% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -6739.252% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -296274.763% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -1783.65% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -722598.462% |
| PepGen Inc. | 17.1 Million USD | -5394.199% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -22468.854% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -162444.637% |
| XOMA Corporation | 118.51 Million USD | -692.713% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -2539110.811% |
| Bionomics Limited | 117.62 Million USD | -698.711% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -16647.023% |
| uniQure N.V. | 130.06 Million USD | -622.337% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -1503.53% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -136854.519% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -21562.624% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -67734.513% |
| Altimmune, Inc. | 175 Thousand USD | -536761.714% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -16647.023% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -18445.361% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1011.121% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -9361.309% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -14628.139% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -9361.309% |
| argenx SE | 15.35 Million USD | -6018.979% |
| Immunome, Inc. | 1.34 Million USD | -70012.537% |
| Verona Pharma plc | 48.37 Million USD | -1842.176% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -10094.314% |
| Shattuck Labs, Inc. | 3.4 Million USD | -27483.911% |
| CervoMed Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -1105203.529% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -559130.952% |
| Moolec Science SA | 99.04 Thousand USD | -948457.236% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -40153.128% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Achilles Therapeutics plc | 1.07 Million USD | -87214.87% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -7226884.615% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -174.323% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -3737.232% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -37480.47% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -484182.474% |
| Beam Therapeutics Inc. | 159.91 Million USD | -487.519% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -206.607% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -112686.074% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -1570405.834% |
| NeurAxis, Inc. | 27.07 Thousand USD | -3470433.043% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -93850.8% |
| Lumos Pharma, Inc. | 6 Million USD | -15558.467% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -5511.538% |
| Palisade Bio, Inc. | 90 Thousand USD | -1043797.778% |
| Nutriband Inc. | 79.82 Thousand USD | -1176844.855% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -2219.315% |
| Neurogene Inc. | 13.37 Million USD | -6925.409% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -3477.306% |
| Athira Pharma, Inc. | 1.21 Million USD | -77098.685% |
| HCW Biologics Inc. | 6.3 Million USD | -14802.611% |
| XOMA Corporation | 118.51 Million USD | -692.713% |
| Nektar Therapeutics | 112.62 Million USD | -734.191% |
| Arvinas, Inc. | 800 Thousand USD | -117338.5% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -6399.6% |
| Merus N.V. | 10.48 Million USD | -8857.933% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -6211.777% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -6896.113% |
| Rezolute, Inc. | 1.66 Million USD | -56496.867% |
| Clene Inc. | 7.15 Million USD | -13036.298% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -1280791.095% |
| BeyondSpring Inc. | 3.36 Million USD | -27828.3% |
| Synlogic, Inc. | 12.49 Million USD | -7421.479% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -2776.984% |
| Krystal Biotech, Inc. | 6.62 Million USD | -14091.964% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -449.68% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -15568.913% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1983197.798% |
| MannKind Corporation | 252.15 Million USD | -272.597% |
| Ikena Oncology, Inc. | 7.18 Million USD | -12985.07% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -472014.573% |
| Gossamer Bio, Inc. | 197.4 Million USD | -375.929% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -180574.615% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -233.955% |
| Mural Oncology plc | 8.91 Million USD | -10443.239% |
| Disc Medicine, Inc. | 1.43 Million USD | -65325.348% |
| Champions Oncology, Inc. | 6.09 Million USD | -15319.465% |
| REGENXBIO Inc. | 82.22 Million USD | -1042.648% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -190082.651% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -21088.724% |
| Vaxart, Inc. | 2.62 Million USD | -35718.071% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -345776.575% |
| Cellectis S.A. | 36.24 Million USD | -2492.39% |
| Longeveron Inc. | 1.44 Million USD | -64783.149% |
| Repare Therapeutics Inc. | 1.01 Million USD | -92920.594% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 17.042% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -1998.568% |
| Revolution Medicines, Inc. | 80.57 Million USD | -1066.004% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -29186.409% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -530695.48% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -763727.642% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -29.641% |
| Denali Therapeutics Inc. | 44.98 Million USD | -1988.677% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -7413.509% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -695321.876% |
| Passage Bio, Inc. | 22.92 Million USD | -3998.896% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -15457.344% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -145109.892% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -4559.102% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -230478.441% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -78983.165% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -201511.159% |
| OmniAb, Inc. | 22.07 Million USD | -4155.982% |
| Anew Medical, Inc. | 1.54 Million USD | -60907.013% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -3078.31% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -10300.841% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -2921.898% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -23073.353% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -1722.27% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -14655.898% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -6549.501% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -139707.738% |
| Alumis Inc. Common Stock | 30.86 Million USD | -2944.42% |
| Equillium, Inc. | 384 Thousand USD | -244563.542% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -15154.23% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -30927.345% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -4751369.175% |
| vTv Therapeutics Inc. | 169 Thousand USD | -555821.893% |
| Bio-Techne Corporation | 319 Million USD | -194.517% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -1548.607% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -426.14% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -5997.93% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -7487.079% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -19444.581% |
| Nkarta, Inc. | 82.27 Million USD | -1041.981% |
| BioCardia, Inc. | 982 Thousand USD | -95572.912% |
| Iterum Therapeutics plc | 18.95 Million USD | -4856.257% |